It's Time to Take Action on External Genital and Perianal Warts (EGW)
Don't know where to start? Here's the support you need right now.
Photo for illustrative purposes only. Not actual patient.
Save on Your Treatment
Take advantage of VEREGEN® copay savings by enrolling in the ANI Pharmaceuticals DERM COPAY SAVINGS PROGRAM. You may pay as little as $25 for your VEREGEN® prescription.* Just download the card and use it when you fill your prescription at the pharmacy!
Questions? Please call 1-844-396-8097
| * | Eligibility rules apply: For qualified patients only. Maximum benefits may apply. For full details regarding the ANI Pharmaceuticals Derm Copay Savings Program, click on the DOWNLOAD YOUR CARD link or call 1-844-396-8097. |
Automatic Savings At The Pharmacy On Veregen® Prescriptions
Most Patients Pay No More Than $0
To find a participating eVoucherRx™ pharmacy visit:
eVoucher Terms and conditions:
*Additional terms and conditions Offer not valid for any individual for whom any part of Veregen® prescription is or will be covered by Medicaid, Medicare (including Medicare Advantage or Part D Prescription Plans), any state prescription drug programs, or any other public payer program. This eVoucher cannot be combined with any other coupon certificate, voucher or similar offer. Offer applies to out-of-pocket (OOP) expenses for Veregen®. Out-of-pocket expenses greater than $0 will be covered up to a maximum of $326 per prescription of actual out-of-pocket expenses per 30-day supply for each of up to three (3) prescription fills. Offer good only in the USA at participating retail pharmacies and cannot be redeemed at government subsidized clinics. ANI Pharmaceuticals, Inc. reserves the right to rescind, revoke or amend this offer without notice. Participation in this program must comply with all applicable state laws and contractual or other obligations as a pharmacy provider. This is not an insurance program. Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein. Offer not extended for prescriptions for: 1) No claims paid by Government-sponsored insurance plans - Medicare, Medicaid, Federal, State, Patient Pharmaceutical Assistance 2) No Pharmacies in states that prohibit the offering of co-pay assistance at the point of dispensing 3) Patients 18 years of age and younger are excluded 4) No cash claims To find a participating eVoucherRx™ pharmacy visit: www.evoucherrx.relayhealth.com/storelookup
Photo for illustrative purposes only. Not actual patients.
EGW=external genital and perianal warts
Important Safety Information
Do not use VEREGEN® (sinecatechins) Ointment, 15% if you are allergic to any ingredient in this product. Do not use VEREGEN® Ointment, 15% for warts in the vagina, cervix, or inside the anus. Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s).
Avoid use of VEREGEN® on open wounds. Do not expose skin that has been treated with VEREGEN® to the sunlight, sunlamps or tanning beds. Tell your doctor if you are using any other type of skin product on the area to be treated. Avoid sexual contact (genital, anal or oral) when VEREGEN® Ointment, 15% is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms.
Be sure to tell the doctor if you have a weak immune system, if you are pregnant or nursing a baby, or if you have used VEREGEN® before. Avoid using this product in patients younger than 18 years of age or for longer than 16 weeks. If your warts do not go away or come back after treatment contact your doctor.
The most common side effects with VEREGEN® Ointment, 15% are local skin and application site reactions including (incidence ≥20%): redness, itching, burning, pain, sores, swelling, hard spots, and rash with blisters.
For more information, consult your healthcare professional.
Please see full Prescribing Information for VEREGEN®.
You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Indication
VEREGEN® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.
Important Safety Information
Do not use VEREGEN® (sinecatechins) Ointment, 15% if you are allergic to any ingredient in this product. Do not use VEREGEN® Ointment, 15% for warts in the vagina, cervix, or inside the anus. Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s).
Avoid use of VEREGEN® on open wounds. Do not expose skin that has been treated with VEREGEN® to the sunlight, sunlamps or tanning beds. Tell your doctor if you are using any other type of skin product on the area to be treated. Avoid sexual contact (genital, anal or oral) when VEREGEN® Ointment, 15% is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms.
Be sure to tell the doctor if you have a weak immune system, if you are pregnant or nursing a baby, or if you have used VEREGEN® before. Avoid using this product in patients younger than 18 years of age or for longer than 16 weeks. If your warts do not go away or come back after treatment contact your doctor.
The most common side effects with VEREGEN® Ointment, 15% are local skin and application site reactions including (incidence ≥20%): redness, itching, burning, pain, sores, swelling, hard spots, and rash with blisters.
For more information, consult your healthcare professional.
Please see full Prescribing Information for VEREGEN®.
You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Indication
VEREGEN® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.
